[Ulcerative colitis. Acute episode]. 2004

A Reissmann, and S C Bischoff, and W Fleig
Martin-Luther-Universität Halle-Wittenberg, Klinik und Poliklinik für Innere Medizin I, Halle.

UI MeSH Term Description Entries
D007166 Immunosuppressive Agents Agents that suppress immune function by one of several mechanisms of action. Classical cytotoxic immunosuppressants act by inhibiting DNA synthesis. Others may act through activation of T-CELLS or by inhibiting the activation of HELPER CELLS. While immunosuppression has been brought about in the past primarily to prevent rejection of transplanted organs, new applications involving mediation of the effects of INTERLEUKINS and other CYTOKINES are emerging. Immunosuppressant,Immunosuppressive Agent,Immunosuppressants,Agent, Immunosuppressive,Agents, Immunosuppressive
D011379 Prognosis A prediction of the probable outcome of a disease based on a individual's condition and the usual course of the disease as seen in similar situations. Prognostic Factor,Prognostic Factors,Factor, Prognostic,Factors, Prognostic,Prognoses
D011446 Prospective Studies Observation of a population for a sufficient number of persons over a sufficient number of years to generate incidence or mortality rates subsequent to the selection of the study group. Prospective Study,Studies, Prospective,Study, Prospective
D012008 Recurrence The return of a sign, symptom, or disease after a remission. Recrudescence,Relapse,Recrudescences,Recurrences,Relapses
D012074 Remission Induction Therapeutic act or process that initiates a response to a complete or partial remission level. Induction of Remission,Induction, Remission,Inductions, Remission,Remission Inductions
D003093 Colitis, Ulcerative Inflammation of the COLON that is predominantly confined to the MUCOSA. Its major symptoms include DIARRHEA, rectal BLEEDING, the passage of MUCUS, and ABDOMINAL PAIN. Colitis Gravis,Idiopathic Proctocolitis,Inflammatory Bowel Disease, Ulcerative Colitis Type,Ulcerative Colitis
D004359 Drug Therapy, Combination Therapy with two or more separate preparations given for a combined effect. Combination Chemotherapy,Polychemotherapy,Chemotherapy, Combination,Combination Drug Therapy,Drug Polytherapy,Therapy, Combination Drug,Chemotherapies, Combination,Combination Chemotherapies,Combination Drug Therapies,Drug Polytherapies,Drug Therapies, Combination,Polychemotherapies,Polytherapies, Drug,Polytherapy, Drug,Therapies, Combination Drug
D005500 Follow-Up Studies Studies in which individuals or populations are followed to assess the outcome of exposures, procedures, or effects of a characteristic, e.g., occurrence of disease. Followup Studies,Follow Up Studies,Follow-Up Study,Followup Study,Studies, Follow-Up,Studies, Followup,Study, Follow-Up,Study, Followup
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000208 Acute Disease Disease having a short and relatively severe course. Acute Diseases,Disease, Acute,Diseases, Acute

Related Publications

A Reissmann, and S C Bischoff, and W Fleig
August 2009, Zeitschrift fur Gastroenterologie,
A Reissmann, and S C Bischoff, and W Fleig
November 1975, Rinsho hoshasen. Clinical radiography,
A Reissmann, and S C Bischoff, and W Fleig
January 1961, Diseases of the colon and rectum,
A Reissmann, and S C Bischoff, and W Fleig
June 1907, British medical journal,
A Reissmann, and S C Bischoff, and W Fleig
January 1961, Diseases of the colon and rectum,
A Reissmann, and S C Bischoff, and W Fleig
July 1964, Postgraduate medicine,
A Reissmann, and S C Bischoff, and W Fleig
October 1957, Lancet (London, England),
A Reissmann, and S C Bischoff, and W Fleig
August 1960, American journal of proctology,
A Reissmann, and S C Bischoff, and W Fleig
December 1987, The American journal of gastroenterology,
A Reissmann, and S C Bischoff, and W Fleig
November 1997, Anales de medicina interna (Madrid, Spain : 1984),
Copied contents to your clipboard!